Gene expression profiling in canine OSA identified mRNA dysregulation of Smo, Ptch1, and Dhh in poor responders, and a recent study found inhibition of Gli function with GANT treatment leads to decreased cell proliferation in canine OSA cell lines [15, 31]. The gene discussed is DHH; the disease is obstructive sleep apnea syndrome.